Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.
OpenAI, Oracle, SoftBank, and MGX are the lead partners in Stargate, according to OpenAI.
SoftBank Group Corp., OpenAI, and Oracle Corp. are forming a $100 billion joint venture to fund artificial intelligence infrastructure, an effort unveiled with President Donald Trump aimed at speeding development of the emerging technology.
US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.
OpenAI CEO Sam Altman, Oracle founder Larry Ellison and SoftBank CEO Masayoshi Son comment on President Trump’s Stargate AI investment project in an interview with FOX News anchor Bret Baier on ‘Special Report.
Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.
The Trump Administration has announced an AI infrastructure joint venture in the U.S. named “Stargate,” comprised of OpenAI, SoftBank Group (OTC:SFTBF) (OTC:SFTBY), Oracle Corp (NYSE:ORCL), and Abu Dhabi’s MGX.
Some of the biggest names in technology have clashed after President Donald Trump unveiled his $500 billion private AI investment project. Earlier this week, Trump announced a joint venture with OpenAI,
The $500B Stargate Initiative, led by Trump, OpenAI, SoftBank, and Oracle, is set to revolutionize U.S. AI infrastructure.
Musk's stance on the issue also contradicts Trump's announcement, who on Tuesday at a White House news conference along with Oracle Chief Technology Officer Larry Ellison, Softbank CEO Masayoshi Son and Open AI CEO Sam Altman,
Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by President Donald Trump, the latest in a feud between the two billionaires that started on OpenAI’s board and is now testing Musk’s influence with the new presidential administration.